Categories
Cardiovascular
Diagnostics
Endocrinology
Health Insurance
Medical Devices
Mental Health
Nutrition
Oncology
Public Health
Sexual Health
Popular Articles
Burdock Root

Washington Post Columnist Gerson Critical Of Justice Ginsburg's Comments On Abortion In NYT Magazine Interview
"There was a scandal this week" involving Supreme Court Justice Ruth Bader Ginsburg"s comments on abortion rights during an interview with the New York Times Magazine, according to Washington Post columnist Michael Gerson. In response to a question on access to abortion and restrictions on Medicaid coverage of the procedure, Ginsburg said, "Frankly I had thought that at the time Roe [v. Wade] was decided, there was concern about population growth and particularly growth in populations that we don"t want to have too many of. So that Roe was going to be then set up for Medicaid funding for abortion." According to Gerson, the "context surrounding this passage is a simplistic, pro-choice rant." He adds, "Abortion, in Ginsburg"s view, is an essential part of sexual equality, thus ending all ethical debate." Ginsburg in the interview also said, "There will never be a woman of means without choice anymore. That just seems to be so obvious." She added, "So we have a policy that affects only poor women, and it can never be otherwise, and I don"t know why this hasn"t been said more often."Gerson writes, "Given this context, can it be argued that Ginsburg -- referring to "populations that we don"t want to have too many of" -- was merely summarizing the views of others and describing the attitudes of the country when Roe v. Wade was decided?" He continues, "It can be argued -- but it is not bloody likely. Who, in Ginsburg"s statement, is the "we"? And who, in 1973, was arguing for the eugenic purposes of abortion?" According to Gerson, "It is more likely that Ginsburg is describing the attitude of some of her own social class -- that abortion is economically important to a "woman of means" and useful in reducing the number of social undesirables."Gerson writes, "The entire Ginsburg interview is a reminder of the risks of lifetime appointments to the Supreme Court." He continues, "Immune from criticism, surrounded by plump cushions of deference, the temperament of a justice can become exaggerated over time." He adds that her statements "would have been disqualifying" had they been made during her own confirmation hearing. "Now she doesn"t give a damn," Gerson says.He continues that Ginsburg"s "timing ... is instructive" because she made the remarks as Supreme Court nominee Sonia Sotomayor is "emphasizing her low-income and minority roots." According to Gerson, "It is estimated that the Hyde Amendment limiting Medicaid abortions has saved one million lives since its passage in 1976 -- some, no doubt, became criminals and some, perhaps, lawyers and judges." He concludes, "It is a defining question for modern liberalism: Are these men and women "populations that we don"t want to have too many of," or are they citizens worthy of justice and capable of contribution?" (Gerson, Washington Post, 7/17).
generic viagra online
Next-Generation Mechanical Heart Pump Implanted In Heart Patients
Three patients at NewYork-Presbyterian Hospital/Columbia University Medical Center were among the first in the United States to be implanted with a next-generation artificial heart pump called the DuraHeart™ Left-Ventricular Assist System. The surgeries took place earlier this year. NewYork-Presbyterian/Columbia is one of only three centers in the U.S. currently enrolling patients in a clinical trial studying the device.
News of the day
Recent Studies And Surveys
Georgetown Policy Report: Long-Term Care in Health Care Reform: Policy Options to Improve Both - Policy - Long-term care reform belongs in health care reform -- "The well-being and financial security of families depend not only on access to affordable medical services, but also on access to affordable, reliable long-term care - the daily assistance and supports that many individuals need because of serious medical conditions or disabilities." This policy brief presents four policy options that merit serious consideration in the current health care reform discussion. ... The first two options would improve long-term care for people with low incomes and limited financial res. These options would modernize Medicaid in important ways, tailoring services better to individual needs and using res more effectively. The third and fourth options aim to strengthen long-term care protections for the broader population; one with better coordination of medical and long-term care for Medicare enrollees; the other by establishing insurance protection for people of all ages and incomes" (Komisar, Tumlinson, Feder, Burke, 7/16). (Note: KHN"s coverage of aging and long term care issues is supported by a grant from The SCAN Foundation.)
Mental Health

New Software To Improve Clinical Trial Performance

TranSenda International, LLC announced today that it is developing a new solution, Cortex, designed to improve an organization"s ability to manage a clinical trial"s performance. Based upon patent-pending ClinBUS® data interchange technology already in use in TranSenda"s Office-Smart solutions, Cortex will enable organizations to leverage the power of access to centralized operational data from all applications used across all clinical studies. For years the industry has struggled with an increasingly fragmented environment of disconnected clinical applications, sites and partners. TranSenda"s Cortex, with its proven ClinBUS technology, represents a breakthrough in managing and controlling studies within a common environment-independent of study data formats and clinical trial applications. With the Cortex clinical trial management performance system, sponsors and Clinical Research Organizations (CROs) will benefit from real-time connectivity across complex partner networks and enterprise environments, delivering superior performance visibility for improved decision support and trial management. With this data now centralized, analysis is greatly enhanced because ClinBUS technology is optimized to make data available in Microsoft® Office SharePoint Server (MOSS). Previously hard-to-get-to operational data can now be easily controlled, communicated and coordinated between people and applications using MOSS. Current industry practice relies on costly custom data connections between applications which are specific to each trial. By connecting all applications and all trials in a single information system, Cortex creates more efficient, cost-effective and sustainable access to important operational data. Cortex accomplishes this by standardizing the exchange of clinical trial management data and its semantics in a centralized server. Standardizing common operational data also facilitates interoperability between various clinical trial applications, including legacy Clinical Trial Management Systems (CTMS). Using ClinBUS data interchange technology, Cortex is also compatible with CDISC ODM data types. Cortex is also designed to facilitate codeless customization by users with SharePoint® experience and by Microsoft Independent Software Vendors (ISVs). This feature enables the extension and customization of clinical processes at a fraction of the cost and time of conventional development environments. Cortex basically unleashes access to operational information across applications and trials and allows it to be used in Microsoft"s powerful Office System for the creation of configurable dashboards, specialized reports, custom workflow and much more. Not only does Cortex unleash operational information to allow organizations to transform it into valuable knowledge, Cortex also enables a new level of "centralized" study management. For example, imagine being able to create custom workflow that generates user alerts based upon any combination of changes in data from interconnected systems. This would greatly improve a sponsor"s ability to respond quickly to prevent delays, unnecessary spending or regulatory non-compliance. An example of a centralized application that can take advantage of the Cortex environment is TranSenda"s Office-Smart Clinical Payment Manager. Site payment information that works on operational data maintained in ClinBUS from diverse CTMS and EDC systems could be managed centrally, helping ensure bottom-line study cost accuracy and meeting upcoming regulatory requirements for disclosure of items of value to healthcare professionals. Site payment and alert management are just two of many centralized solutions that Cortex can support to help fine tune an organization"s ability to effectively manage trials. "Cortex is a unique solution that will address the challenges faced by clinical business partners who are trying to increase efficiency while working within an increasingly complex environment of geographical dispersion and disconnected software," said Robert Webber, TranSenda"s President and CEO. "Working closely with Microsoft on our ClinBUS technology has given TranSenda the very latest software capabilities to uniquely address these challenges." Value-added SharePoint web parts to assist with reporting study enrollment, subject completion, Case Report Form (CRF) progress, and clinical site payment tracking are also planned for the upcoming release. Commercial availability will be announced at a later date. TranSenda

NAyan commented:

Me and my colleagues authored one of India\'s most extensive reports on clinical trials. Drop me a mail if you are interested in a copy. My email is ntaluk@gmail.com.

Some of the topics we included are:

- Market Trends
- Growth Drivers
- Regulatory Bodies and Framework
- Major Players.
-Etc.
We interviewed over 200 individuals and firms to collect the data in what we believe is one of the most detailed study on the subject in India.

Nayan
ntaluk@gmail.com

02.03.2011


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009